🇺🇸 FDA

Drug profile · INN

levodopa

CORBILTA (PREVIOUSLY LEVODOPA/CARBIDOPA/ENTACAPONE SANDOZ)

approved N04BA02
US status
approved
Patents linked
8
News articles
0

Quick answer

levodopa (CORBILTA (PREVIOUSLY LEVODOPA/CARBIDOPA/ENTACAPONE SANDOZ)) is an FDA-listed pharmaceutical active ingredient. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.

Key facts

INN levodopa
Brand CORBILTA (PREVIOUSLY LEVODOPA/CARBIDOPA/ENTACAPONE SANDOZ)
Route ORAL
Formulation POWDER
ATC code N04BA02

Related patents

Search patents →

Frequently asked questions

What is levodopa?

levodopa (CORBILTA (PREVIOUSLY LEVODOPA/CARBIDOPA/ENTACAPONE SANDOZ)) is an FDA-listed pharmaceutical active ingredient. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.

What is the brand name for levodopa?

CORBILTA (PREVIOUSLY LEVODOPA/CARBIDOPA/ENTACAPONE SANDOZ) is a marketed brand name for levodopa. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of levodopa?

levodopa has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.